---
title: "Insulet Corp. Stock Underperforms Wednesday When Compared To Competitors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298505959.md"
description: "Insulet Corp. (PODD) shares fell 3.06% to $137.92 on Wednesday, underperforming competitors like Eli Lilly and DexCom during a broader market decline. This marks the stock's third consecutive day of losses, with trading volume exceeding its 50-day average."
datetime: "2026-09-09T21:16:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298505959.md)
  - [en](https://longbridge.com/en/news/298505959.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298505959.md)
generator: "portal-rs"
---

# Insulet Corp. Stock Underperforms Wednesday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Insulet Corp. (PODD) slid 3.06% to $137.92 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.48% to 7,636.36 and Dow Jones Industrial Average falling 0.77% to 52,380.66.

This was the stock's third consecutive day of losses.

Insulet Corp. closed 61.14% short of its 52-week high of $354.88, which the company reached on November 20th.

The stock underperformed when compared to some of its competitors Wednesday, as Eli Lilly & Co. (LLY) rose 0.03% to $1,124.21, DexCom Inc. (DXCM) fell 0.77% to $83.88, and Johnson & Johnson (JNJ) fell 0.76% to $267.08.

Trading volume (2.1 M) eclipsed its 50-day average volume of 1.6 M.

Data source: Dow Jones Market Data, FactSet. Data compiled September 9, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

09-09-26 1716ET

### Related Stocks

- [PODD.US](https://longbridge.com/en/quote/PODD.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [DXCM.US](https://longbridge.com/en/quote/DXCM.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)

## Related News & Research

- [Insulet Reprices $475 Million Term Loans, Expands Revolver to $750 Million in Credit Amendment](https://longbridge.com/en/news/299685094.md)
- [Insulet replaces USD 475 million term loans with lower-margin facility under amended credit agreement with Morgan Stanley agent](https://longbridge.com/en/news/299684116.md)
- [How Phase 3 Sjögren’s Results At Amgen (AMGN) Has Changed Its Investment Story](https://longbridge.com/en/news/300175029.md)
- [SAP (XTRA:SAP) Could Be 10% Undervalued As Cloud Revenue Jumps 24%](https://longbridge.com/en/news/300174678.md)
- [Does Earnings Miss Change The Bull Case For Texas Pacific Land Stock?](https://longbridge.com/en/news/300174710.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**